Evidence map›Paper›PMID 37274897›Full record

ArticleArchives of Razi Institute2022

Design and Development of a New Method for the Production of Nanotoxoids from

E Abbasi, T Zahraei Salehi, R Pilehchian Langroudi, M Tebyanian, R Yahyaraeyat

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of Razi Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

E AbbasiDepartment of Pathology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
T Zahraei SalehiDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
R Pilehchian LangroudiDepartment of Anaerobic Bacterial Vaccine Research and Production, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
M TebyanianDepartment of Biotechnology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
R YahyaraeyatDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Razi Vaccine and Serum Research Institute · IRUniversity of Tehran · IRIslamic Azad University, Science and Research Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, a nanoparticle-based strategy has shown that non-denatured protein toxins can be used to enhance the appropriate immune response. Once the toxin reacts between the nanoparticles and the protein (toxin), it loses its toxicity because it does not attach to its ligand at the cell surface. The results of the nanoparticle and toxin complex show that the nanoparticles facilitate the internal release of the toxin.

Indexed as

Clostridium perfringensPolymersAnimalsDose-Response Relationship, DrugMiceSheepToxoidsPolymersToxoidsBeta toxinClostridium perfringensNanoparticlesPoly lactic-co-glycolic acid

Identifiers

PMID37274897
PMCPMC10237558
OpenAlexW3204094112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.